Nevada
Fee-For-Service Medicaid Coverage of Screening
Yes
Highlighted Disparity
Data by race/ethnicity are not available for Nevada.
Lung Cancer Rates
New Cases:
- The rate of new lung cancer cases is 53 and significantly lower than the national rate of 58.
- Nevada ranks 14th among all states, placing it in the average tier.
- The change in the rate of new cases over the last five years is not available for Nevada.
5-Year Survival Rate:
- The percent of people still alive five years after being diagnosed with lung cancer (the survival rate) is 24% nationally.
- Nevada is one of the 6 states for which survival data is not available as they do not track cases after diagnosis.
Early Diagnosis:
- The early diagnosis rate is not available for Nevada.
Lung Cancer Treatment
Surgical Treatment:
- Nationally, 21% of cases undergo surgery as part of the first course of treatment.
- Data on surgery as part of the first course of treatment is not available for Nevada.
Lack of Treatment:
- Nationally, 21% of cases receive no treatment.
- Data on lack of treatment is not available for Nevada.
Screening
Screening for High Risk:
- In Nevada, 1% of those at high risk were screened, which was significantly lower than the national rate of 6%.
- It ranks 49th among all states, placing it in the bottom tier.
Medicaid Coverage:
- Nevada was one of the 40 states whose Medicaid fee-for-service programs covered lung cancer screening as of September 2021.
- In addition, their program used recommended guidelines for determining eligibility and did not require prior authorization or cost sharing.
Prevention
Tobacco Use:
- The smoking rate in Nevada is 16% and not significantly different than the national rate of 15%.
- It ranks 23rd among all states, placing it in the average tier.
Radon:
- In Nevada, 13% of radon tests results were at or above the action level recommended by EPA.
- It ranks 12th among all states, placing it in the above average tier.
Racial & Ethnic Disparities
Black Americans:
- The rate of new lung cancer cases is 51 per 100,000 population among Black Americans in Nevada, significantly lower than the rate of 60 among Black Americans nationally, and significantly lower than the rate of 60 among whites in Nevada.
- Survival rates by race and ethnicity are not available for Nevada at this time.
- 5% of Black Americans with lung cancer in Nevada did not receive any treatment, significantly lower than the rate of 23% among Black Americans nationally, and not significantly different than the rate of 6% among whites in Nevada.
- Other lung cancer rates are not available for Black Americans in Nevada due to too few cases over the time period to allow for accurate analysis.
Latino Americans:
- The rate of new lung cancer cases is 26 per 100,000 population among Latinos in Nevada, significantly lower than the rate of 29 among Latinos nationally, and significantly lower than the rate of 60 among whites in Nevada.
- Survival rates by race and ethnicity are not available for Nevada at this time.
- 4% of Latinos with lung cancer in Nevada underwent surgery, significantly lower than the rate of 21% among Latinos nationally, and not significantly different than the rate of 3% among whites in Nevada.
- 5% of Latinos with lung cancer in Nevada did not receive any treatment, significantly lower than the rate of 26% among Latinos nationally, and not significantly different than the rate of 6% among whites in Nevada.
- Other lung cancer rates are not available for Latino Americans in Nevada due to too few cases over the time period to allow for accurate analysis.
Asian Americans or Pacific Islanders:
- The rate of new lung cancer cases is 34 per 100,000 population among Asian Americans or Pacific Islanders in Nevada, not significantly different than the rate of 34 among Asian Americans or Pacific Islanders nationally, and significantly lower than the rate of 60 among whites in Nevada.
- Survival rates by race and ethnicity are not available for Nevada at this time.
- 6% of Asian Americans or Pacific Islanders with lung cancer in Nevada did not receive any treatment, significantly lower than the rate of 22% among Asian Americans or Pacific Islanders nationally, and not significantly different than the rate of 6% among whites in Nevada.
- Other lung cancer rates are not available for Asian Americans or Pacific Islanders in Nevada due to too few cases over the time period to allow for accurate analysis.
Indigenous Peoples:
- The rate of new lung cancer cases is 41 per 100,000 population among Indigenous Peoples (American Indians/Alaska Natives) in Nevada, not significantly different than the rate of 41 among Indigenous Peoples nationally, and significantly lower than the rate of 60 among whites in Nevada.
- State-level survival rates are not available for Indigenous Peoples at this time. Nationally, the five-year survival rate among Indigenous Peoples is 19%, 11% lower than among white Americans.
- Other lung cancer rates are not available for Indigenous Peoples (American Indians/Alaska Natives) in Nevada due to too few cases over the time period to allow for accurate analysis.
Summary
Early diagnosis data is not available for Nevada. When this rate increases, we can anticipate that the surgery rate would increase, as surgery is often the recommended treatment for those diagnosed at an earlier stage. In addition, when cases are found earlier, we would expect the five-year survival rate to increase.
Nevada has improved access to screening by covering it through its fee-for-service Medicaid program. The Lung Association encourages all states to cover lung cancer screening based on recommended guidelines across all fee-for-service and managed care plans without any financial or administrative barriers in their Medicaid programs.